ARIEL3: A phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC) Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Ledermann, J.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Lin, K. K.; Sun, J.; Giordano, H.; Coleman, R.

authors

Publication Date

  • September 1, 2017

webpage

published in

category

volume

  • 28